Additionally, higher expression of Trx1 and TrxR1 in NSCLC subsets were positively associated with disease advancement, leading to poor overall survival of patients with LUAD (Supplementary Fig. S1e). Here, KMT2A is linked to non-small cell lung carcinoma.